These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 20797690)

  • 1. Mutations in DHDPSL are responsible for primary hyperoxaluria type III.
    Belostotsky R; Seboun E; Idelson GH; Milliner DS; Becker-Cohen R; Rinat C; Monico CG; Feinstein S; Ben-Shalom E; Magen D; Weissman I; Charon C; Frishberg Y
    Am J Hum Genet; 2010 Sep; 87(3):392-9. PubMed ID: 20797690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updated genetic testing of Italian patients referred with a clinical diagnosis of primary hyperoxaluria.
    Pelle A; Cuccurullo A; Mancini C; Sebastiano R; Stallone G; Negrisolo S; Benetti E; Peruzzi L; Petrarulo M; De Marchi M; Marangella M; Amoroso A; Giachino D; Mandrile G
    J Nephrol; 2017 Apr; 30(2):219-225. PubMed ID: 26946417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis.
    Monico CG; Rossetti S; Belostotsky R; Cogal AG; Herges RM; Seide BM; Olson JB; Bergstrahl EJ; Williams HJ; Haley WE; Frishberg Y; Milliner DS
    Clin J Am Soc Nephrol; 2011 Sep; 6(9):2289-95. PubMed ID: 21896830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary hyperoxaluria type III--a model for studying perturbations in glyoxylate metabolism.
    Belostotsky R; Pitt JJ; Frishberg Y
    J Mol Med (Berl); 2012 Dec; 90(12):1497-504. PubMed ID: 22729392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Mutations in DHDPSL are Responsible for Primary Hyperoxaluria Type III.
    Assimos D
    J Urol; 2011 Apr; 185(4):1312. PubMed ID: 22115483
    [No Abstract]   [Full Text] [Related]  

  • 6. Structural and biochemical studies of human 4-hydroxy-2-oxoglutarate aldolase: implications for hydroxyproline metabolism in primary hyperoxaluria.
    Riedel TJ; Johnson LC; Knight J; Hantgan RR; Holmes RP; Lowther WT
    PLoS One; 2011; 6(10):e26021. PubMed ID: 21998747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type 3.
    Williams EL; Bockenhauer D; van't Hoff WG; Johri N; Laing C; Sinha MD; Unwin R; Viljoen A; Rumsby G
    Nephrol Dial Transplant; 2012 Aug; 27(8):3191-5. PubMed ID: 22391140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Hydroxy-2-oxoglutarate aldolase inactivity in primary hyperoxaluria type 3 and glyoxylate reductase inhibition.
    Riedel TJ; Knight J; Murray MS; Milliner DS; Holmes RP; Lowther WT
    Biochim Biophys Acta; 2012 Oct; 1822(10):1544-52. PubMed ID: 22771891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three novel deletions in the alanine:glyoxylate aminotransferase gene of three patients with type 1 hyperoxaluria.
    Coulter-Mackie MB; Rumsby G; Applegarth DA; Toone JR
    Mol Genet Metab; 2001 Nov; 74(3):314-21. PubMed ID: 11708860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation Hot Spot Region in the HOGA1 Gene Associated with Primary Hyperoxaluria Type 3 in the Chinese Population.
    Wang W; Liu Y; Kang L; He R; Song J; Li Y; Li J; Yang Y
    Kidney Blood Press Res; 2019; 44(4):743-753. PubMed ID: 31401635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of the inactivation of Hydroxyproline dehydrogenase on urinary oxalate and glycolate excretion in mouse models of primary hyperoxaluria.
    Buchalski B; Wood KD; Challa A; Fargue S; Holmes RP; Lowther WT; Knight J
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165633. PubMed ID: 31821850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOGA1 Gene Mutations of Primary Hyperoxaluria Type 3 in Tunisian Patients.
    M'dimegh S; Aquaviva-Bourdain C; Omezzine A; Souche G; M'barek I; Abidi K; Gargah T; Abroug S; Bouslama A
    J Clin Lab Anal; 2017 May; 31(3):. PubMed ID: 27561601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of compound heterozygous patients with primary hyperoxaluria type 1: clinical evaluations and in silico investigations.
    Kanoun H; Jarraya F; Maalej B; Lahiani A; Mahfoudh H; Makni F; Hachicha J; Fakhfakh F
    BMC Nephrol; 2017 Oct; 18(1):303. PubMed ID: 28969594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two Novel HOGA1 Splicing Mutations Identified in a Chinese Patient with Primary Hyperoxaluria Type 3.
    Wang X; Zhao X; Wang X; Yao J; Zhang F; Lang Y; Tuffery-Giraud S; Bottillo I; Shao L
    Am J Nephrol; 2015; 42(1):78-84. PubMed ID: 26340091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation spectrum of primary hyperoxaluria type 1 in Tunisia: implication for diagnosis in North Africa.
    Nagara M; Tiar A; Ben Halim N; Ben Rhouma F; Messaoud O; Bouyacoub Y; Kefi R; Hassayoun S; Zouari N; Ben Ammar MS; Abdelhak S; Chemli J
    Gene; 2013 Sep; 527(1):316-20. PubMed ID: 23810941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2.
    Cregeen DP; Williams EL; Hulton S; Rumsby G
    Hum Mutat; 2003 Dec; 22(6):497. PubMed ID: 14635115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folding Defects Leading to Primary Hyperoxaluria.
    Oppici E; Dindo M; Conter C; Borri Voltattorni C; Cellini B
    Handb Exp Pharmacol; 2018; 245():313-343. PubMed ID: 29071511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nine novel HOGA1 gene mutations identified in primary hyperoxaluria type 3 and distinct clinical and biochemical characteristics in Chinese children.
    Fang X; He L; Xu G; Lin H; Xu M; Geng H
    Pediatr Nephrol; 2019 Oct; 34(10):1785-1790. PubMed ID: 31123811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular degradation of 4-hydroxy-2-oxoglutarate aldolase leads to absolute deficiency in primary hyperoxaluria type 3.
    MacDonald JR; Huang AD; Loomes KM
    FEBS Lett; 2016 May; 590(10):1467-76. PubMed ID: 27096395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies.
    Beck BB; Baasner A; Buescher A; Habbig S; Reintjes N; Kemper MJ; Sikora P; Mache C; Pohl M; Stahl M; Toenshoff B; Pape L; Fehrenbach H; Jacob DE; Grohe B; Wolf MT; Nürnberg G; Yigit G; Salido EC; Hoppe B
    Eur J Hum Genet; 2013 Feb; 21(2):162-72. PubMed ID: 22781098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.